EXELIXIS, INC.
An oncology-focused biotech that discovers and develops medicines for hard-to-treat cancers.
EXEL | NDAQ
Overview
Corporate Details
- ISIN(s):
- US30161Q1040
- LEI:
- Country:
- United States of America
- Address:
- 1851 HARBOR BAY PARKWAY, 94502 ALAMEDA
- Website:
- https://www.exelixis.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines for difficult-to-treat cancers. The company leverages its expertise in genomics, chemistry, and biology to advance a diversified portfolio of therapies. Its research and development programs encompass both in-house small molecule discovery and the advancement of innovative biotherapeutics, including bispecific antibodies and antibody-drug conjugates. Through internal research and strategic collaborations, Exelixis aims to develop next-generation and first-in-class treatments to improve outcomes for cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all EXELIXIS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EXELIXIS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EXELIXIS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
